- Home
- XENE vs ACLS Comparison
XENE vs ACLS Comparison
Compare XENE & ACLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XENE
- ACLS
- Stock Information
- Founded
- XENE 1996
- ACLS 1995
- Country
- XENE Canada
- ACLS United States
- Employees
- XENE N/A
- ACLS N/A
- Industry
- XENE Biotechnology: Pharmaceutical Preparations
- ACLS Industrial Machinery/Components
- Sector
- XENE Health Care
- ACLS Technology
- Exchange
- XENE Nasdaq
- ACLS Nasdaq
- Market Cap
- XENE 2.9B
- ACLS 2.6B
- IPO Year
- XENE 2014
- ACLS 2000
- Fundamental
- Price
- XENE $42.30
- ACLS $83.14
- Analyst Decision
- XENE Strong Buy
- ACLS Buy
- Analyst Count
- XENE 10
- ACLS 7
- Target Price
- XENE $53.00
- ACLS $97.00
- AVG Volume (30 Days)
- XENE 742.2K
- ACLS 675.1K
- Earning Date
- XENE 11-03-2025
- ACLS 11-04-2025
- Dividend Yield
- XENE N/A
- ACLS N/A
- EPS Growth
- XENE N/A
- ACLS N/A
- EPS
- XENE N/A
- ACLS 4.91
- Revenue
- XENE $7,500,000.00
- ACLS $896,089,000.00
- Revenue This Year
- XENE N/A
- ACLS N/A
- Revenue Next Year
- XENE $207.88
- ACLS $5.53
- P/E Ratio
- XENE N/A
- ACLS $16.94
- Revenue Growth
- XENE N/A
- ACLS N/A
- 52 Week Low
- XENE $26.74
- ACLS $40.40
- 52 Week High
- XENE $46.00
- ACLS $102.93
- Technical
- Relative Strength Index (RSI)
- XENE 59.76
- ACLS 45.49
- Support Level
- XENE $40.79
- ACLS $81.96
- Resistance Level
- XENE $43.33
- ACLS $85.53
- Average True Range (ATR)
- XENE 1.59
- ACLS 3.01
- MACD
- XENE -0.05
- ACLS -0.11
- Stochastic Oscillator
- XENE 60.49
- ACLS 56.00
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.
About ACLS Axcelis Technologies Inc.
Axcelis Technologies Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips. In addition to equipment, the company provides aftermarket lifecycle products and services, including used tools, spare parts, equipment upgrades, maintenance services, and customer training. Geographically, the group has a business presence in North America, Asia Pacific, and Europe, of which key revenue is derived from the Asia Pacific.